BYSI

$1.79

Market ClosedAs of Mar 17, 8:00 PM UTC

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Recent News

Simply Wall St.
Oct 28, 2025

Here's Why We're Watching BeyondSpring's (NASDAQ:BYSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
May 15, 2025

Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth?

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.